Training general practitioners in the ABC


Journal

ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 28 08 2020
accepted: 10 10 2020
entrez: 29 7 2021
pubmed: 30 7 2021
medline: 30 7 2021
Statut: epublish

Résumé

This study assessed the effectiveness of a 3.5-h training session for general practitioners (GPs) in providing brief stop-smoking advice and compared two methods of giving advice - ABC

Identifiants

pubmed: 34322552
doi: 10.1183/23120541.00621-2020
pii: 00621-2020
pmc: PMC8311138
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

Copyright ©ERS 2021.

Déclaration de conflit d'intérêts

Conflict of interest: S. Kastaun has nothing to disclose. Conflict of interest: V. Leve has nothing to disclose. Conflict of interest: J. Hildebrandt has nothing to disclose. Conflict of interest: C. Funke has nothing to disclose. Conflict of interest: S. Klosterhalfen has nothing to disclose. Conflict of interest: D. Lubisch has nothing to disclose. Conflict of interest: O. Reddemann has nothing to disclose. Conflict of interest: H. McRobbie reports honoraria for speaking at smoking cessation meetings and attending advisory board meetings from Pfizer and Johnson & Johnson outside the submitted work. Conflict of interest: T. Raupach reports personal fees from Pfizer, Novartis, GlaxoSmithKline, AstraZeneca and Roche as a speaker in activities related to continuing medical education, and grants from Pfizer and Johnson & Johnson, outside the submitted work. Conflict of interest: R. West reports grants and personal fees from Pfizer, Johnson & Johnson and GlaxoSmithKline, and personal fees from acting as an advisor to the UK's National Centre for Smoking Cessation and Training, outside the submitted work. Conflict of interest: S. Wilm has nothing to disclose. Conflict of interest: W. Viechtbauer has nothing to disclose. Conflict of interest: D. Kotz has nothing to disclose.

Références

NPJ Prim Care Respir Med. 2017 Jun 9;27(1):38
pubmed: 28600490
J Gen Intern Med. 2007 Apr;22(4):478-84
pubmed: 17372796
Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):334-41
pubmed: 21450679
Dtsch Arztebl Int. 2020 Jan 6;117(1-2):7-13
pubmed: 32008606
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Drug Alcohol Rev. 2012 Jul;31(5):693-7
pubmed: 22486986
Tob Control. 2008 Jun;17(3):173-6
pubmed: 18522969
Nicotine Tob Res. 2014 Jan;16(1):1-10
pubmed: 23873981
Cochrane Database Syst Rev. 2019 Jun 05;6:CD009670
pubmed: 31166007
PLoS One. 2016 Dec 21;11(12):e0168482
pubmed: 28002498
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Tob Induc Dis. 2017 Nov 2;15:41
pubmed: 29142531
Am J Prev Med. 2008 Aug;35(2):158-76
pubmed: 18617085
Eur J Public Health. 2017 Feb 1;27(1):129-134
pubmed: 28177479
J R Soc Med. 2003 May;96(5):219-22
pubmed: 12724430
BMC Fam Pract. 2019 Jul 27;20(1):107
pubmed: 31351460
JAMA Intern Med. 2015 Sep;175(9):1509-16
pubmed: 26076313
Addiction. 2011 Mar;106(3):631-8
pubmed: 21134020
Drug Alcohol Depend. 2013 Feb 1;128(1-2):15-9
pubmed: 22943961
Tob Control. 2007 Feb;16(1):15-21
pubmed: 17297068
Eur J Public Health. 2005 Apr;15(2):140-5
pubmed: 15941758
Health Educ Behav. 2018 Dec;45(6):888-897
pubmed: 29862845
Nicotine Tob Res. 2018 Nov 15;20(12):1525-1528
pubmed: 29099979
Cochrane Database Syst Rev. 2012 May 16;(5):CD000214
pubmed: 22592671
Addiction. 2012 Oct;107(10):1878-82
pubmed: 22551065
Cochrane Database Syst Rev. 2013 May 31;(5):CD000165
pubmed: 23728631
Cochrane Database Syst Rev. 2012 Oct 17;10:CD008286
pubmed: 23076944

Auteurs

Sabrina Kastaun (S)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Verena Leve (V)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Jaqueline Hildebrandt (J)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Christian Funke (C)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Stephanie Klosterhalfen (S)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Diana Lubisch (D)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Olaf Reddemann (O)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Hayden McRobbie (H)

University of New South Wales, National Drug and Alcohol Research Centre, Randwick, Australia.
Lakes District Health Board, Rotorua, New Zealand.

Tobias Raupach (T)

Dept of Cardiology and Pneumology, University Medical Centre Göttingen, Göttingen, Germany.
Behavioral Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK.

Robert West (R)

Behavioral Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK.

Stefan Wilm (S)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Wolfgang Viechtbauer (W)

Dept of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.

Daniel Kotz (D)

Institute of General Practice (Ifam), Centre for Health and Society (chs), Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Behavioral Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK.
Dept of Family Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands.

Classifications MeSH